Erasca, Inc. ERAS 深 滬
已收盤 06-18 16:00:00 美东时间
13.67
-0.310
-2.22%
華盛通- 最 高14.77
- 今 開14.64
- 成交量 964.21万股
- 最 低 13.60
- 昨 收 13.98
- 總市值 42.51亿
- 52周最高 24.28
- 市盈率 靜 --
- 換手率 3.10%
- 52周最低 1.235
- 委 比 73.80%
- 總股本 3.11亿
- 歷史最高 24.47
- 量 比 2.52
- 振 幅 8.37%
- 歷史最低 1.01
- 每 手 1
- 風險率 5.92%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股夜盘 | 博埃家具涨16.12%，ACM Research, Inc. Class A涨11.63%
博埃家具涨16.12%；ACM Research, Inc. Class A涨11.63%；艾克尔科技涨6.34%
06-17 15:01
美股夜盘 | 迈威尔科技涨7.27%，Satellogic Inc. Class A涨6.32%
迈威尔科技涨7.27%；Satellogic Inc. Class A涨6.32%；BitMine Immersion Technologies涨6.29%
06-08 09:01
美股大行评级 | 绩后暴跌，博通仍获11家大行上调目标价；CrowdStrike获21家大行集体上调目标价；Netskope、Veeva Systems惨遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持Vivos Therapeutics"买入"评级，目标价从3美元升至3.1美元；富国银行：维持Veeva Systems"超配"评级，目标价从317美元升至320美元
06-05 11:33
This KeyBanc Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday
Top analysts upgrade MUR, UNH, ESNT, and ERAS stocks. For more rating changes, see analyst ratings page. See what analysts think of UNH stock.
06-04 20:43
B of A Securities Upgrades Erasca to Neutral, Raises Price Target to $16
B of A Securities analyst Alec Stranahan upgrades Erasca (NASDAQ:ERAS) from Underperform to Neutral and raises the price target from $9 to $16.
06-04 17:23
Abercrombie & Fitch Upbeat Q1 Earnings, Joins Digital Turbine, Dycom Industries And Other Big Stocks Moving Higher On Wednesday
Dow Jones up 300 points with gains from Abercrombie & Fitch, Digital Turbine, Dycom Industries, Qfin Holdings, Editas Medicine, and others.
05-27 22:51
美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
Mizuho Maintains Outperform on Erasca, Lowers Price Target to $26
Mizuho analyst Joseph Catanzaro maintains Erasca (NASDAQ:ERAS) with a Outperform and lowers the price target from $28 to $26.
05-12 21:01
Erasca Q1 EPS $(0.60) Misses $(0.22) Estimate
Erasca (NASDAQ:ERAS) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.22) by 172.73 percent. This is a 445.45 percent decrease over losses of $(0.11) per share from the
05-12 05:28
